American International Group’s Novavax NVAX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-55,832
Closed -$267K 1805
2024
Q1
$267K Buy
55,832
+8,492
+18% +$39.4K ﹤0.01% 1978
2023
Q4
$227K Buy
47,340
+3,886
+9% +$23.8K ﹤0.01% 2109
2023
Q3
$315K Buy
43,454
+1,545
+4% +$12.3K ﹤0.01% 1866
2023
Q2
$311K Buy
41,909
+40,632
+3,182% +$320K ﹤0.01% 1933
2023
Q1
$8.85K Buy
1,277
+82
+7% +$754 ﹤0.01% 2954
2022
Q4
$12.3K Sell
1,195
-27
-2% -$476 ﹤0.01% 2973
2022
Q3
$22K Buy
1,222
+4
+0.3% +$173 ﹤0.01% 2966
2022
Q2
$63K Sell
1,218
-213
-15% -$11K ﹤0.01% 2796
2022
Q1
$105K Hold
1,431
﹤0.01% 2575
2021
Q4
$205K Sell
1,431
-19
-1% -$3.27K ﹤0.01% 2358
2021
Q3
$301K Sell
1,450
-111
-7% -$24.5K ﹤0.01% 2174
2021
Q2
$331 Sell
1,561
-35,695
-96% -$6.54M ﹤0.01% 2190
2021
Q1
$6.75K Sell
37,256
-82
-0.2% -$16.3K 0.02% 715
2020
Q4
$4.16K Buy
37,338
+478
+1% +$50.8K 0.02% 840
2020
Q3
$3.99M Buy
36,860
+1,215
+3% +$148K 0.02% 748
2020
Q2
$2.97M Buy
35,645
+16,633
+87% +$636K 0.01% 832
2020
Q1
$258K Buy
19,012
+2,374
+14% +$20.1K ﹤0.01% 1768
2019
Q4
$66K Buy
16,638
+1,535
+10% +$6.66K ﹤0.01% 2812
2019
Q3
$76K Buy
15,103
+182
+1% +$996 ﹤0.01% 2738
2019
Q2
$87K Buy
14,921
+2,766
+23% +$21.8K ﹤0.01% 2754
2019
Q1
$134K Sell
12,155
-394
-3% -$12.4K ﹤0.01% 2445
2018
Q4
$462K Sell
12,549
-96
-0.8% -$3.72K ﹤0.01% 1717
2018
Q3
$475K Buy
12,645
+228
+2% +$6.42K ﹤0.01% 1931
2018
Q2
$333K Buy
12,417
+2,431
+24% +$82.2K ﹤0.01% 2078
2018
Q1
$419K Sell
9,986
-537
-5% -$21.6K ﹤0.01% 1841
2017
Q4
$261K Buy
10,523
+1,085
+11% +$26.5K ﹤0.01% 2162
2017
Q3
$215K Buy
9,438
+706
+8% +$15.8K ﹤0.01% 2252
2017
Q2
$201K Buy
8,732
+419
+5% +$8.22K ﹤0.01% 2263
2017
Q1
$213K Buy
8,313
+549
+7% +$15.1K ﹤0.01% 2143
2016
Q4
$196K Sell
7,764
-20
-0.3% -$583 ﹤0.01% 2186
2016
Q3
$324K Buy
7,784
+12
+0.2% +$1.55K ﹤0.01% 1859
2016
Q2
$1.13M Sell
7,772
-4,490
-37% -$515K ﹤0.01% 1108
2016
Q1
$1.27M Buy
12,262
+205
+2% +$22K ﹤0.01% 1342
2015
Q4
$2.02M Buy
12,057
+1,401
+13% +$216K 0.01% 1097
2015
Q3
$1.51M Sell
10,656
-2,312
-18% -$518K 0.01% 1224
2015
Q2
$2.89M Buy
12,968
+483
+4% +$84.9K 0.01% 1005
2015
Q1
$2.07M Sell
12,485
-2,257
-15% -$366K 0.01% 1152
2014
Q4
$1.75M Buy
14,742
+177
+1% +$18.5K 0.01% 1191
2014
Q3
$1.21M Buy
14,565
+1,142
+9% +$103K 0.01% 1420
2014
Q2
$1.24M Buy
13,423
+6,863
+105% +$603K 0.01% 1415
2014
Q1
$594K Sell
6,560
-4,929
-43% -$551K ﹤0.01% 1945
2013
Q4
$1.18M Buy
11,489
+6,914
+151% +$488K 0.01% 1366
2013
Q3
$289K Buy
4,575
+92
+2% +$5.18K ﹤0.01% 2394
2013
Q2
$184K Buy
+4,483
New +$194K ﹤0.01% 2652

Other funds holding NVAX

American International Group's NVAX Position: Q2 2024 in Review

American International Group sold out of Novavax (NVAX) in Q2 2024, closing a stake of 55,832 shares — an estimated $267K sold.

American International Group first reported a position in NVAX in Q2 2013 and held it in 44 quarters. The position peaked at $3.99M in Q3 2020. 229 funds tracked by Wall St. Rank hold NVAX as of Q2 2024.

  • American International Group reported no remaining Novavax position as of Q2 2024 after selling out during the quarter.
  • American International Group sold 55,832 Novavax shares in Q2 2024, an estimated $267K.
  • American International Group first reported a position in Novavax in Q2 2013 and held it in 44 quarters.
  • American International Group's Novavax position peaked at $3.99M in Q3 2020.
  • 229 funds tracked by Wall St. Rank held Novavax as of Q2 2024.

Based on American International Group's 13F filing for Q2 2024, filed 13 Aug 2024.